Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients

BACKGROUND: High body mass index (BMI) has been associated with worse clinical outcomes in patients with early-stage breast cancer (BC), and its negative effects could be mediated by hyperglycemia/diabetes. However, the prognostic impact of high BMI in early-stage HER2-positive (HER2+) BC patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ligorio, Francesca, Zambelli, Luca, Bottiglieri, Achille, Castagnoli, Lorenzo, Zattarin, Emma, Lobefaro, Riccardo, Ottini, Arianna, Vingiani, Andrea, Pupa, Serenella M., Bianchi, Giulia V., Capri, Giuseppe, Pruneri, Giancarlo, de Braud, Filippo, Vernieri, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053837/
https://www.ncbi.nlm.nih.gov/pubmed/33948122
http://dx.doi.org/10.1177/17588359211006960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053837/
https://www.ncbi.nlm.nih.gov/pubmed/33948122
http://dx.doi.org/10.1177/17588359211006960

Ejemplares similares